Lieff Cabraser Reminds Galena Biopharma Investors Of Upcoming Deadline In Class Action Litigation

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the May 5, 2014 deadline to move for appointment as lead plaintiff in the securities class litigation brought on behalf of those who purchased or otherwise acquired the securities of Galena Biopharma, Inc. (“Galena” or the “Company”) (Nasdaq:GALE) between May 9, 2013 and March 17, 2014, inclusive (the “Class Period”).

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC